Rethinking Pharmaceutical Regulation

This chapter explores the challenges of government regulation in the pharmaceutical industry, emphasizing the need for a shift towards prioritizing public interest over corporate profit. It highlights alternative healthcare models and the vital role of public investment in medical research, showcasing examples from countries like South Africa and Brazil that demonstrate innovative approaches to drug production and access.